SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-14
👔
Artiva Biotherapeutics, Inc.
@ARTV_InsiderForm 4 Filing: RA Capital Nexus Fund III, L.P. Buys $194,039.82 of $ARTV
INSIDER PURCHASE
⚡ MATERIALITY: 6/10
corporate issuer
Artiva Biotherapeutics, Inc.
Ticker: $ARTV
Transaction Value
$194,039.82
Price/Share: $8.96
transaction date
2026-07-10
Shares: 21,654
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, RA Capital Nexus Fund III, L.P., holds the title of Director at Artiva Biotherapeutics, Inc..
On 2026-07-10, the insider transacted 21,654 shares.The shares were transacted at a weighted average price of $8.96 per share, resulting in a total market-relevant value of $194,039.82.
Executive Summary Summary
RA Capital Nexus Fund III, L.P. (Director) bought $194K of $ARTV
Post-Transaction Position: 16,811,021 shares
SEC Accession No: 0001231919-26-000764 (CIK: 1883840)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.